Our mission is to improve patient outcomes and expand healthcare access using AI tools to democratize echo, the most commonly used tool for detection of heart risk.

Heart disease is the #1 killer worldwide

Echocardiography (ultrasound of the heart) is the first test of choice for cardiologists since, compared to other imaging methods, as it’s

Less Expensive

More Mobile

Non-Invasive & Radiation Free

Us2.ai is building a future where everyone, from the most advanced tech-driven regions to the most resource-constrained communities, can have equal access to high quality, consistent, and inexpensive echo analysis, for a better heart and a better life.

Us2.ai is a spinoff with support from Singapore’s Agency for Science, Technology and Research (A*STAR), built upon a major cardiovascular research platform across 11 countries.  We’ve partnered with top-tier echo core labs in the US and Europe to revolutionize ultrasound bringing AI enhanced imaging to all of us. 



The company’s founders bring decades of experience building technology companies from zero to IPO, running echo core labs and leading global, cardiological clinical trials.  Together, we’ve partnered with data scientists from Singapore’s Bioinformatics Institute and the Institute for High-Performance Computing to make life easier for echo specialists everywhere.

News and Publications

Automating the fight against heart disease

A profile of Dr Carolyn Lam in Tattler Asia.

Automating the fight against heart disease | January 03, 2022

Groundbreaking AI validation

Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study

Groundbreaking AI validation | December 02, 2021

Highly Cited Researchers

Dr Lam recognized as pioneer with multiple highly-cited papers in top 1% for field and year

Highly Cited Researchers | November 18, 2021

Fedex Small Business Award

Announced at the Forbes Asia #100 to Watch Webinar

Fedex Small Business Award | October 22, 2021

Johnson & Johnson Innovation

Us2.ai wins a Digital Technologies of Tomorrow challenge.

Johnson & Johnson Innovation | October 07, 2021

Us2.ai FDA clearance

AI driven heart exams

“Opening up access to millions more people…”

AI driven heart exams | September 30, 2021

FDA clearance

Us2.ai receives FDA clearance for the first fully automated solution measuring both 2D and Doppler cardiac ultrasound images

FDA clearance | September 15, 2021

Forbes Asia 100 to Watch

Forbes Asia have selected Us2.ai for the inaugural 100 to Watch list

Forbes Asia 100 to Watch | September 03, 2021

New Heart Failure Guidelines

What is new in the 2021 ESC HF guidelines regarding patients with EF>40%?

New Heart Failure Guidelines | August 29, 2021

Healthcare Trailblazers

Channel News Asia – The Hidden Layer: Healthcare Trailblazers

Healthcare Trailblazers | March 24, 2021

Big breakthroughs in Singapore

Inc. Magazine – Big breakthroughs are happening in one of the world’s hottest technology centers

Big breakthroughs in Singapore | November 11, 2020

Roche Healthcare Transformers

Fun interview on automating the fight against heart disease with AI

Roche Healthcare Transformers | September 30, 2020

eko.ai in Publications

Founding Team

Dr Carolyn Lam

Director of the Clinical & Translational Research Office, National Heart Centre of Singapore. Professor of Cardiology at Duke-NUS Graduate Medical School. Leads multiple global clinical trials.

Received the L’Oreal Women in Science award. Currently on the Editorial Boards of Circulation, and the European Journal of Heart Failure, with prior editorial posts at 10 other journals. Has published over 175 peer reviewed articles and books. Host of the weekly medical podcast Circulation on the Run, and co-host of the television show Body & Soul.

PhD Univ. Groningen. Masters Mayo Clinic. Stanford GSB exec. program.


James Hare

Co-founder and President of eDreams (2014 IPO), one of Europe’s largest e-commerce sites with a global presence in 44 countries and over €4.5 billion in annual bookings. Biz dev and marketing roles throughout US, Europe and Asia, with EFI, UbiSoft, Netscape and the World Economic Forum.

MBA Stanford. BA Harvard.

Dr Yoran Hummel

Founder and GM of the Groningen Imaging Core Lab, coordinating all echocardiographic logistics in several large multicenter global clinical trials. Cardiovascular researcher with a special interest in echocardiography, diastology and cardio-mechanics. 

More than 50 publications in peer reviewed journals on cardiotoxicity, genetics and point-of-care echo, but always with cardiac function/failure as common denominator. 

Phd Univ. Groningen.



Dr Martin Cowie

Chair of the European Society of Cardiology Digital Health Committe.  Chair of Cardiology, Imperial College London. Hon. Consultant Cardiologist, Royal Brompton Hospital. Ex-Chair British Society for Heart Failure. Member, European Society of Cardiology’s EU Affairs Committee. Major research interests in health technology assessment with a particular focus on new technologies: diagnostics, drugs or devices.

MSc in Epidemiology, London School of Hygiene and Tropical Medicine.

Dr Bijan Dorri

Advisor for Medical Technologies, A*STAR. Former CTO, GE Healthcare Systems, Molecular Imaging and CT. Affiliate Professor Univ. of Washington. Managing Director, China Technology Center, for GE.

PhD Univ. of Washington in Mechanical Engineering. BS in Chemical Engineering, Shiraz Univ.

Dr Ken Stein

Dr. Ken Stein is currently Senior Vice President and Chief Medical Officer for Rhythm Management and Global Health Policy at Boston Scientific.

Ken is a Phi Beta Kappa graduate of Harvard College, and earned his MD from New York University School of Medicine. He completed his medical internship, residency, cardiology and cardiac electrophysiology training at The New York-Presbyterian Hospital/Weill Cornell Medical Center. 

Jeremy Lim

Mr Jeremy Lim is Partner, Health & Life Sciences Asia Pacific, at Oliver Wyman. He advises senior officials at public sector agencies and has extensive experience consulting and advising multinational private and NGO clients on national and regional strategies for go-to-market plans and implementation, government engagement and public-private partnerships.

Jeremy is also active in academia, holding appointments at several universities. He teaches at the National University of Singapore (Saw Swee Hock School of Public Health, and Duke-NUS medical school), and in 2013 authored Myth or Magic: The Singapore Healthcare System, a book that draws lessons from the Singapore health system for health reform efforts in other countries.

Prior to joining Oliver Wyman, Jeremy trained in surgery and public health. He has worked in senior executive roles in both public and private sectors, including time spent as a senior official in the Ministry of Health Singapore where he was also involved in a number of ‘Whole of Government’ initiatives.

Dr Scott Solomon

Professor of Medicine, Harvard. Director, Noninvasive Cardiology, Brigham and Women’s Hospital. Director, Cardiac Imaging Core Lab, Brigham and Women’s Hospital. Doctor of Medicine, Harvard. AB Neuroscience, Williams College.

Dr Justin Ezekowitz

Professor, Division of Cardiology, University of Alberta. Director of the Heart Function Clinic, Mazankowski Alberta Heart Institute. Co-Director of the Canadian VIGOUR Centre.